Novel nanoemulsion based lipid nanosystems for favorable in vitro and in vivo characteristics of curcumin

International Journal of Pharmaceutics

Volumn 504, Issue 1-2, 2016, Pages 80-88

  Wan, Kun ^a   Sun, Lili ^a   Hu, Xueyuan ^a   Yan, Zijun ^a   Zhang, Yonghong ^a   Zhang, Xue ^a   Zhang, Jingqing ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Anti cancer cytotoxicity; Characteristics; In situ absorption; In vivo kinetic property; Nanoemulsion based lipid nanosystems

Indexed keywords

CURCUMIN; NANOCARRIER; SOLID LIPID NANOPARTICLE; WATER OIL CREAM; ANTINEOPLASTIC AGENT; EMULSION; LIPID; NANOPARTICLE;

A549 CELL LINE; ANIMAL EXPERIMENT; ANIMAL MODEL; APPARENT PERMEABILITY; AREA UNDER THE CURVE; ARTICLE; BIOEQUIVALENCE; CANCER INHIBITION; CELL VIABILITY; CYTOTOXICITY; DRUG BIOAVAILABILITY; DRUG CLEARANCE; DRUG DELIVERY SYSTEM; DRUG RELEASE; GASTROINTESTINAL ABSORPTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LUNG CANCER; MALE; MAXIMUM PLASMA CONCENTRATION; MEAN RESIDENCE TIME; NANOEMULSION; NONHUMAN; PRIORITY JOURNAL; RAT; TIME TO MAXIMUM PLASMA CONCENTRATION; TRANSMISSION ELECTRON MICROSCOPY; ANIMAL; BIOAVAILABILITY; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; EMULSION; INTESTINE ABSORPTION; ORAL DRUG ADMINISTRATION; SPRAGUE DAWLEY RAT; TUMOR CELL LINE;

ADMINISTRATION, ORAL; ANIMALS; ANTINEOPLASTIC AGENTS; BIOLOGICAL AVAILABILITY; CELL LINE, TUMOR; CELL SURVIVAL; CURCUMIN; DRUG DELIVERY SYSTEMS; DRUG LIBERATION; EMULSIONS; HUMANS; INTESTINAL ABSORPTION; LIPIDS; MALE; NANOPARTICLES; RATS, SPRAGUE-DAWLEY;

EID: 84962432607     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2016.03.055     Document Type: Article

References (53)

1. H. Almeida, M.H. Amaral, P. Lobão, A.C. Silva, and J.M. Loboa Applications of polymeric and lipid nanoparticles in ophthalmic pharmaceutical formulations: present and future considerations J. Pharm. Pharm. Sci. 17 2014 278 293
2. A. Beloqui, M.Á. Solinís, A. Delgado, C. Evora, A. Isla, and A. Rodríguez-Gascón Fate of nanostructured lipid carriers (NLCs) following the oral route: design, pharmacokinetics and biodistribution J. Microencapsul. 31 2014 1 8
3. B.V. Bonifácio, P.B. Silva, M.A. Ramos, K.M. Negri, T.M. Bauab, and M. Chorilli Nanotechnology-based drug delivery systems and herbal medicines: a review Int. J. Nanomed. 9 2014 1 15
4. C. Carbone, A. Campisi, T. Musumeci, G. Raciti, R. Bonfanti, and G. Puglisi FA-loaded lipid drug delivery systems: preparation, characterization and biological studies Eur. J. Pharm. Sci. 52 2014 12 20
5. S. Chaudhary, T. Garg, R.S. Murthy, G. Rath, and A.K. Goyal Recent approaches of lipid-based delivery system for lymphatic targeting via oral route J. Drug Target. 22 2014 871 882
6. S. Chaurasia, R.R. Patel, P. Chaubey, N. Kumar, G. Khan, and B. Mishra Lipopolysaccharide based oral nanocarriers for the improvement of bioavailability and anticancer efficacy of curcumin Carbohydr. Polym. 130 2015 9 17
7. Z. Fan, X. Duan, H. Cai, L. Wang, M. Li, J. Qu, W. Li, Y. Wang, and J. Wang Curcumin inhibits the invasion of lung cancer cells by modulating the PKCα/Nox-2/ROS/ATF-2/MMP-9 signaling pathway Oncol. Rep. 34 2015 691 698
8. O.M. Feeney, H.D. Williams, C.W. Pouton, and C.J. Porter 'Stealth' lipid-based formulations: poly(ethylene glycol)-mediated digestion inhibition improves oral bioavailability of a model poorly water soluble drug J. Control. Release. 192 2014 219 227
9. L. Gastaldi, L. Battaglia, E. Peira, D. Chirio, E. Muntoni, I. Solazzi, F. Gallarate, and F. Dosio Solid lipid nanoparticles as vehicles of drugs to the brain: current state of the art Eur. J. Pharm. Biopharm. 87 2014 433 444
10. V. Gordon, G. Marom, and S. Magdassi Formation of hydrophilic nanofibers from nanoemulsions through electrospinning Int. J. Pharm. 478 2015 172 179
11. R.M. Heredia, P.S. Boeris, M.A. Biasutti, G.A. López, N.S. Paulucci, and G.I. Lucchesi Coordinated response of phospholipids and acyl components of membrane lipids in Pseudomonas putida A (ATCC 12633) under stress caused by cationic surfactants Microbiology 160 2014 2618 2626
12. J. Hu, D. Chen, R. Jiang, Q. Tan, B. Zhu, and J. Zhang Improved absorption and in vivo kinetic characteristics of nanoemulsions containing evodiamine-phospholipid nanocomplex Int. J. Nanomed. 9 2014 4411 4420
13. J. Hu, L. Sun, D. Zhao, L. Zhang, M. Ye, Q. Tan, C. Fang, H. Wang, and J. Zhang Supermolecular evodiamine loaded water-in-oil nanoemulsions: enhanced physicochemical and biological characteristics Eur. J. Pharm. Biopharm. 88 2014 556 564
14. S.K. Jain, M.S. Gill, H.S. Pawar, and S. Suresh Novel curcumin diclofenac conjugate enhanced curcumin bioavailability and efficacy in streptococcal cell wall-induced arthritis Indian J. Pharm. Sci. 76 2014 415 422
15. D.J. Jang, S.T. Kim, E. Oh, and K. Lee Enhanced oral bioavailability and antiasthmatic efficacy of curcumin using redispersible dry emulsion Biomed. Mater. Eng. 24 2014 917 930
16. J.H. Kim, Y. Kim, K.H. Bae, T.G. Park, J.H. Lee, and K. Park Tumor-targeted delivery of paclitaxel using low density lipoprotein-mimetic solid lipid nanoparticles Mol. Pharm. 12 2015 1230 1241
17. A.K. Kushwaha, P.R. Vuddanda, P. Karunanidhi, S.K. Singh, and S. Singh Development and evaluation of solid lipid nanoparticles of raloxifene hydrochloride for enhanced bioavailability Biomed. Res. Int. 2013 2013 584549
18. B. Lasa-Saracíbar, M.Á. Aznar, H. Lana, I. Aizpún, A.G. Gil, and M.J. Blanco-Prieto Lipid nanoparticles protect from edelfosine toxicity in vivo Int. J. Pharm. 474 2014 1 5
19. B. Lasa-Saracíbar, M. Guada, V. Sebastián, and M.J. Blanco-Prieto In vitro intestinal co-culture cell model to evaluate intestinal absorption of edelfosine lipid nanoparticles Curr. Top. Med. Chem. 14 2014 1124 1132
20. C.K. Lee, S.H. Ki, and J.S. Choi Effects of oral curcumin on the pharmacokinetics of intravenous and oral etoposide in rats: possible role of intestinal CYP3A and P-gp inhibition by curcumin Biopharm. Drug Dispos. 32 2011 245 251
21. D.M. Lundvig, S.W. Pennings, K.M. Brouwer, M. Mtaya-Mlangwa, E. Mugonzibwa, A.M. Kuijpers-Jagtman, F.A. Wagener, and J.W. Von den Hoff Cytoprotective responses in HaCaT keratinocytes exposed to high doses of curcumin Exp. Cell. Res. 336 2015 298 307
22. L. Mazzarino, R. Borsali, and E. Lemos-Senna Mucoadhesive films containing chitosan-coated nanoparticles: a new strategy for buccal curcumin release J. Pharm. Sci. 103 2014 3764 3771
23. S.B. Mello, E.R. Tavares, A. Bulgarelli, E. Bonfá, and R.C. Maranhão Intra-articular methotrexate associated to lipid nanoemulsions: anti-inflammatory effect upon antigen-induced arthritis Int. J. Nanomed. 8 2013 443 449
24. C. Oelkrug, C.M. Lange, E. Wenzel, S. Fricke, M. Hartke, J. Simasi, and A. Schubert Analysis of the tumoricidal and anti-cachectic potential of curcumin Anticancer Res. 34 2014 4781 4788
25. G. Parashar, and N. Capalash Promoter methylation-independent reactivation of PAX1 by curcumin and resveratrol is mediated by UHRF1 Clin. Exp. Med. 2015 10.1007/s10238-015-0366-1
26. H. Rachmawati, D.K. Budiputra, and R. Mauludin Curcumin nanoemulsion for transdermal application: formulation and evaluation Drug Dev. Ind. Pharm. 41 2015 560 566
27. R. Raj, P. Mongia, A. Ram, and N.K. Jain Enhanced skin delivery of aceclofenac via hydrogel-based solid lipid nanoparticles Artif. Cells Nanomed. Biotechnol. 2015 10.3109/21691401.2015.1036997
28. P. Ramalingam, and Y.T. Ko Enhanced oral delivery of curcumin from N-trimethyl chitosan surface-modified solid lipid nanoparticles: pharmacokinetic and brain distribution evaluations Pharm. Res. 32 2015 389 402
29. Y. Sahbaz, H.D. Williams, T.H. Nguyen, J. Saunders, L. Ford, S.A. Charman, P.J. Scammells, and C.J. Porter Transformation of poorly water-soluble drugs into lipophilic ionic liquids enhances oral drug exposure from lipid based formulations Mol. Pharm. 12 2015 1980 1991
30. R. Sareen, K. Nath, N. Jain, and K.L. Dhar Curcumin loaded microsponges for colon targeting in inflammatory bowel disease: fabrication, optimization, and in vitro and pharmacodynamic evaluation Biomed. Res. Int. 2014 2014 340701
31. R. Sareen, N. Jain, and K.L. Dhar Curcumin-zn(II) complex for enhanced solubility and stability: an approach for improved delivery and pharmacodynamic effects Pharm. Dev. Technol. 2015 10.3109/10837450.2015.1041042
32. P. Shukla, P. Dwivedi, P.K. Gupta, and P.R. Mishra Optimization of novel tocopheryl acetate nanoemulsions for parenteral delivery of curcumin for therapeutic intervention of sepsis Expert Opin. Drug Deliv. 11 2014 1697 1712
33. M.S. Singh, and A. Lamprecht Cargoing P-gp inhibitors via nanoparticle sensitizes tumor cells against doxorubicin Int. J. Pharm. 478 2015 745 752
34. B. Singh, R. Singh, S. Bandyopadhyay, R. Kapil, and B. Garg Optimized nanoemulsifying systems with enhanced bioavailability of carvedilol Colloids Surf. B: Biointerfaces 101 2013 465 474
35. C. Slabbert, L.H. Plessis, and A.F. Kotzé Evaluation of the physical properties and stability of two lipid drug delivery systems containing mefloquine Int. J. Pharm. 409 2011 209 215
36. S. Sood, K. Jain, and K. Gowthamarajan Optimization of curcumin nanoemulsion for intranasal delivery using design of experiment and its toxicity assessment Colloids Surf. B: Biointerfaces 113 2014 330 337
37. Q.Y. Tan, N.N. Hu, G.D. Liu, H.F. Yin, L. Zhang, H. Wang, L.Y. Lu, and J.Q. Zhang Role of a novel pyridostigmine bromide-phospholipid nanocomplex in improving oral bioavailability Arch. Pharm. Res. 35 2012 499 508
38. Q. Tan, Y. Li, J. Wu, H. Mei, C. Zhao, and J. Zhang An optimized molecular inclusion complex of diferuloylmethane: enhanced physical properties and biological activity Int. J. Nanomed. 5 2012 5385 5393
39. Q. Tan, J. Wu, Y. Li, H. Mei, C. Zhao, and J. Zhang A supermolecular curcumin for enhanced antiproliferative and proapoptotic activities: molecular characteristics, computer modeling and in vivo pharmacokinetics Nanotechnology 24 2013 035102
40. D.K. Thukral, S. Dumoga, and A.K. Mishra Solid lipid nanoparticles: promising therapeutic nanocarriers for drug delivery Curr. Drug Deliv. 11 2014 771 791
41. C. Vitorino, A. Almeida, J. Sousa, I. Lamarche, P. Gobin, S. Marchand, W. Couet, J.C. Olivier, and A. Pais Passive and active strategies for transdermal delivery using co-encapsulating nanostructured lipid carriers: in vitro vs. in vivo studies Eur. J. Pharm. Biopharm. 86 2014 133 144
42. B.N. Waghela, A. Sharma, S. Dhumale, S.M. Pandey, and C. Pathak Curcumin conjugated with PLGA potentiates sustainability, anti-proliferative activity and apoptosis in human colon carcinoma cells PLoS One 10 2015 e0117526
43. J. Wang, W. Ma, and P. Tu The mechanism of self-assembled mixed micelles in improving curcumin oral absorption: in vitro and in vivo Colloids Surf. B: Biointerfaces 133 2015 108 119
44. M. Waseem, and S. Parvez Neuroprotective activities of curcumin and quercetin with potential relevance to mitochondrial dysfunction induced by oxaliplatin Protoplasma 2015 10.1007/s00709-015-0821-6
45. X. Wei, T.H. Senanayake, A. Bohling, and S.V. Vinogradov Targeted nanogel conjugate for improved stability and cellular permeability of curcumin: synthesis pharmacokinetics, and tumor growth inhibition Mol. Pharm. 11 2014 3112 3122
46. K. Xiao, J. Jiang, C. Guan, C. Dong, G. Wang, L. Bai, J. Sun, C. Hu, and C. Bai Curcumin induces autophagy via activating the AMPK signaling pathway in lung adenocarcinoma cells J. Pharmacol. Sci. 123 2013 102 109
47. Y. Yang, X. Wu, Z. Wei, Y. Dou, D. Zhao, T. Wang, D. Bian, B. Tong, Y. Xia, Y. Xia, and Y. Dai Oral curcumin has anti-arthritic efficacy through somatostatin generation via cAMP/PKA and Ca(2+)/CaMKII signaling pathways in the small intestine Pharmacol. Res. 95-96 2015 71 81
48. M.X. Ye, Y.L. Zhao, Y. Li, Q. Miao, Z.K. Li, X.L. Ren, L.Q. Song, H. Yin, and J. Zhang Curcumin reverses cis-platin resistance and promotes human lung adenocarcinoma A549/DDP cell apoptosis through HIF-1α and caspase-3 mechanisms Phytomedicine 19 2012 779 787
49. K. Yoncheva, K. Kamenova, T. Perperieva, V. Hadjimitova, P. Donchev, K. Kaloyanov, S. Konstantinov, M. Kondeva-Burdina, V. Tzankova, and P. Petrov Cationic triblock copolymer micelles enhance antioxidant activity, intracellular uptake and cytotoxicity of curcumin Int. J. Pharm. 490 2015 298 307
50. J.Q. Zhang, Z.R. Zhang, H. Yang, Q.Y. Tan, S.R. Qin, and X.L. Qiu Lyophilized paclitaxel magnetoliposomes as a potential drug delivery system for breast carcinoma via parenteral administration: in vitro and in vivo studies Pharm. Res. 22 2005 573 583
51. J. Zhang, J. Liu, X.L. Li, and B.R. Jasti Preparation and characterization of solid lipid nanoparticles containing silibinin Drug Deliv. 14 2007 381 387
52. M. Zhong, Y. Feng, H. Liao, X. Hu, S. Wan, B. Zhu, M. Zhang, H. Xiong, Y. Zhou, and J. Zhang Azithromycin cationic non-lecithoid nano/microparticles improve bioavailability and targeting efficiency Pharm. Res. 31 2014 2857 2867
53. L. Zou, W. Liu, C. Liu, H. Xiao, and D.J. McClements Utilizing food matrix effects to enhance nutraceutical bioavailability: increase of curcumin bioaccessibility using excipient emulsions J. Agric. Food Chem. 63 2015 2052 2062